Analysis | Metabolite Name | Measured Value | Units | Group |
---|---|---|---|---|
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.3328 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.3328 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.4153 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.4673 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.4910 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.5203 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.5291 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.5794 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.6204 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.6247 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.6473 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.6804 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.7026 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.7028 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.7187 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.7200 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.7496 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.7704 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.7880 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.7886 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.8515 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.8543 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.9007 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.9121 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.9601 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.9755 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.9759 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.9882 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.0000 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.0003 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.0117 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.0187 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.0224 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.0628 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.0891 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.0972 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.1007 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.1012 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.1228 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.1375 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.1379 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.1424 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.1443 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.2027 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.2834 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.2889 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.3207 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.3212 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.4290 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.4397 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.4423 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.4679 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.4713 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.9301 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 2.1680 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPA (16:0) | 2.9608 | Peak area | Diabetic Neuropathy |